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ABSTRACT
Introduction The COVID-19 pandemic has led to a 
rapid implementation of telemedicine for the provision of 
maternal and newborn healthcare. The objective of this 
study was to document the experiences with providing 
telemedicine for maternal and newborn healthcare during 
the pandemic among healthcare professionals globally.
Methods The second round of a global online survey 
of maternal and newborn health professionals was 
conducted, disseminated in 11 languages. Data were 
collected between 5 July and 10 September 2020. The 
questionnaire included questions regarding background, 
preparedness and response to COVID-19, and experiences 
with providing telemedicine. Descriptive statistics and 
qualitative thematic analysis were used to analyse 
responses, disaggregated by country income level.
Results Responses from 1060 maternal and newborn 
health professionals were analysed. Telemedicine was 
used by 58% of health professionals and two- fifths of 
them reported not receiving guidelines on the provision 
of telemedicine. Key telemedicine practices included 
online birth preparedness classes, antenatal and 
postnatal care by video/phone, a COVID-19 helpline and 
online psychosocial counselling. Challenges reported 
lack of infrastructure and technological literacy, limited 
monitoring, financial and language barriers, lack of non- 
verbal feedback and bonding, and distrust from patients. 
Telemedicine was considered as an important alternative 
to in- person consultations. However, health providers 
emphasised the lower quality of care and risk of increasing 
the already existing inequalities in access to healthcare.
Conclusions Telemedicine has been applied globally to 
address disruptions of care provision during the COVID-19 
pandemic. However, some crucial aspects of maternal 
and newborn healthcare seem difficult to deliver by 
telemedicine. More research regarding the effectiveness, 
efficacy and quality of telemedicine for maternal healthcare 
in different contexts is needed before considering long- 
term adaptations in provision of care away from face- 
to- face interactions. Clear guidelines for care provision 
and approaches to minimising socioeconomic and 
technological inequalities in access to care are urgently 
needed.
INTRODUCTION
The WHO declared COVID-19 a pandemic 
on 11 March 2020, as a consequence of the 
more than 118 000 cases spread over 110 
countries and the sustained risk of further 
global spread.1 The overall response strategy 
in many countries for fighting the pandemic 
included early diagnosis, patient isolation, 
monitoring of contacts, isolation of suspected 
Key questions
What is already known?
 ► Telemedicine is the delivery of healthcare services 
by healthcare professionals from distance through 
using information and communication technologies 
for the exchange of valid and correct information.
 ► Telemedicine for maternal and newborn health can 
safely be used to deliver certain components of care 
in highly controlled settings where the technology is 
available and accessible to patients.
 ► Telemedicine has been applied rapidly and on a 
wide scale during the COVID-19 pandemic to replace 
face- to- face visits along the continuum of maternal 
and newborn healthcare.
What are the new findings?
 ► Maternal and newborn healthcare providers globally 
considered telemedicine of benefit during the pan-
demic and applied it on a wide scale for different 
aspects of maternal and newborn healthcare.
 ► The rapid adaptation to provision of care via tele-
medicine was not optimally supported by guidelines, 
training for health providers, adequate equipment, 
reimbursement for cost of connectivity and insur-
ance payments for care provided remotely.
 ► Healthcare providers worldwide reported not being 
able to reach a substantial group of families by tele-
medicine and encountered different barriers in pro-
viding high- quality maternity care by telemedicine, 
and such challenges were more prominent in low- 
income and middle- income countries.
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and confirmed cases, and some extent of lockdown.2 In 
this context, the vital role of telemedicine, video consul-
tations in particular, rapidly increased in order to reduce 
the risk of transmission, especially in settings where 
insufficient personal protective equipment was available 
for the health workforce. The call for implementing 
telehealth rapidly has never been louder, especially in 
high- income countries (HICs) where technological 
resources are widely available.3–5 As a consequence, an 
updated framework for telemedicine in the COVID-19 
pandemic for aiding national governments in defining 
their strategy against COVID-19 was proposed at the start 
of the pandemic, advising telehealth for all routine care 
and (suspected) COVID-19 positive cases with mild symp-
toms.4 This framework and other variations have been 
used on a large scale by governments and health systems 
globally to define and implement their public health 
response to the COVID-19 outbreak while maintaining 
the provision of essential health services and avoiding the 
so- called ‘COVID-19 collateral’.4 6 7
According to the WHO, telehealth is the delivery of 
healthcare services by healthcare professionals from 
distance through using information and communication 
technologies for the exchange of valid and correct infor-
mation.8 Sometimes the term telemedicine is specifically 
used to refer to service delivery by physicians only, while 
telehealth includes service provision by nurses, pharma-
cists and other health professionals. In a broader defini-
tion, the term telehealth also includes the interactions 
between healthcare providers (eg, delivery of training, 
team meetings) and the interaction of a patient with 
technology in the absence of a health provider (eg, an 
automated phone line, a health application (app) on a 
mobile phone).9 In this paper, we use the terms telemed-
icine and telehealth synonymously and interchangeably.8 
A wide variety of telehealth interventions exists today, 
including the use of mobile phone apps, online health 
education modules, web portals, wearable devices, text 
messaging (SMS) and live audio- visual communication.9 
The benefits of investing in telemedicine (sometimes 
also referred to as m- health or e- health10–12) have been 
discussed in the literature mainly from a public health 
perspective, documenting the many successes in different 
health service domains and countries,13–15 ranging from 
economic efficiency to overcoming distance barriers in 
remote areas.16 Telemedicine applications seem most 
commonly used and evaluated for the management 
of chronic diseases and mental disorders in HICs.17–20 
Recently, the use of telehealth has expanded dramatically 
during the COVID-19 pandemic due to the necessity of 
maintaining service provision while ensuring physical 
distancing as a strategy for slowing down the transmis-
sion of the virus, and limited accessibility of healthcare to 
both patients and providers.3
Previous epidemic outbreaks and events disruptive to 
health systems showed the potential of telemedicine in 
avoiding further spread of an epidemic disease and main-
taining some provision of general healthcare.4 A mobile 
app named Ebola Contact Tracing could successfully 
monitor and trace contacts of confirmed cases during 
the Ebola virus outbreak in Sierra Leone and healthcare 
providers were educated and trained via a virtual tuto-
rial.21 22 Studies also explored the use of telehealth in the 
context of natural disasters and conflicts, with promising 
results. In the aftermath of two hurricanes in the USA in 
2017, telemedicine was successfully used for the imple-
mentation of free two- way video consultations for victims, 
although the lack of infrastructure and Wi- Fi access were 
cited as serious challenges.23
Since the start of the COVID-19 pandemic, telehealth 
has been increasingly implemented in many countries 
and different health domains to maintain health service 
provision to some extent.24 Several studies have reported 
positive results in terms of providers’ and patients’ experi-
ences, and clinical outcomes,25 26 but the evidence base so 
far is limited and covers a narrow range of health services 
and contexts. For handling confirmed COVID-19 cases 
with mild symptoms, the maximum use of telemedicine 
for guaranteeing providers’ and other patients’ safety has 
not been questioned as an essential part of reducing the 
spread of the virus.27 28 On the other hand, the necessity 
for and evidence regarding providing some elements of 
care for healthy pregnant women and newborns through 
telemedicine remain scarce.29
The evidence on telehealth interventions in maternal 
and newborn healthcare before the COVID-19 pandemic 
is mixed. Two recent systematic reviews found that tele-
health interventions were associated with improvements 
in obstetric outcomes, perinatal smoking cessation, 
continuation of breast feeding, monitoring of high- 
risk pregnancies and early access to medical abortion 
services.30 31 The included studies presented a wide 
variety of telehealth interventions in maternal healthcare, 
including use of mobile phone apps, wearable devices, 
SMS and live audio- visual communication. However, only 
studies conducted in HICs and China, a rapidly growing 
middle- income country (MIC), were included in both 
reviews. Robust evidence from low/middle- income coun-
tries (LMICs) is lacking, mainly due to poor methodical 
quality of studies and their narrow scope (often focusing 
on a single application in a specific setting).32 SMS support 
Key questions
What do the new findings imply?
 ► Pre- existing inequalities in access to high- quality care might have 
increased by the large scale and rapid implementation of telemedi-
cine during the COVID-19 pandemic in different settings.
 ► Uptake of telemedicine by women was hampered by various factors 
such as internet connection problems, lack of the necessary equip-
ment, digital illiteracy, and distrust.
 ► In- depth research is needed to formalise evidence- based guide-
lines for the implementation of telemedicine along the continuum 
of maternal and newborn care, as lessons learnt for building back 
beyond the COVID-19 pandemic and also for future emergency 
preparedness.
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for women during pregnancy seemed the most prom-
ising and commonly evaluated telehealth intervention in 
low- income country (LIC) contexts, and was associated 
with increased utilisation of healthcare, early initiation 
of breast feeding, uptake of recommended prenatal and 
postnatal care (PNC) consultations, skilled birth atten-
dance and infant vaccination.10 15 32 33 Telehealth appli-
cations for maternal health have been implemented also 
in conflict settings and among migrant women before 
the COVID-19 pandemic, where they appear useful for 
providing maternal health education.34–36
The importance of telehealth for maintaining the 
provision and use of essential maternal and newborn 
health services during the COVID-19 pandemic has been 
highlighted by the WHO.29 In its operational guidance 
for the COVID-19 context, the WHO identified health 
interventions during the antenatal, intrapartum and 
postnatal periods as essential services, and suggested the 
use of telemedicine when the technology is available.29 
Evidence regarding its implementation, effectiveness, 
feasibility, cost- effectiveness and health outcomes is begin-
ning to emerge but remains scarce. Available reports, 
mostly commentaries and grey literature, have high-
lighted some challenges and concerns for implementing 
telemedicine in maternal and newborn health alongside 
its advantages. The availability of technology and connec-
tivity seem to pose a serious bottleneck, together with 
high start- up costs and lack of health insurance reim-
bursement for care provided remotely.37 38 Concerns 
regarding a ‘digital divide’, meaning increasing maternal 
and newborn health disparities and inequities as a conse-
quence of access to technology and connectivity, have 
also been raised.39 40
Despite the efforts to supplement the reduction in 
the provision of in- person maternal and newborn care 
by telemedicine during COVID-19, little is known about 
the actual implementation of these efforts and barriers to 
their effectiveness as perceived by healthcare providers. 
This paper documents the findings of a rapid online 
global survey of maternal and newborn health profes-
sionals during the COVID-19 pandemic, focusing on 
their experience of providing care to pregnant and post-
partum women and their newborns using telemedicine.
METHODS
Study design
We present the findings from the second round of a 
repeated cross- sectional online survey of maternal and 
newborn healthcare providers. We focus on the appli-
cation of telemedicine for maintaining the provision of 
maternal and newborn healthcare during the COVID-19 
outbreak. The survey targeted midwives, nurses, obste-
tricians/gynaecologists, neonatologists and other health 
professionals. An invitation to complete the survey was 
distributed to those who responded to the first round of 
the survey, and to other healthcare providers through 
personal networks of the multicountry research team 
members, maternal/newborn platforms and social media 
(eg, Facebook, Twitter, WhatsApp groups). Additional 
details about the study design, sampling and findings of 
the first round of the survey were published previously.41
Questionnaire
A team of international collaborators adapted the ques-
tionnaire used in the first round of the survey in light 
of the evolving situation of the pandemic. The team 
included health professionals and experts in health 
systems, maternal health epidemiologists and public 
health researchers, acknowledged in a previously 
published commentary42 and paper based on the first 
round of the global survey.41 The core structure of the 
first survey round was maintained and we collected data 
on respondents’ background, preparedness for COVID-
19, response to COVID-19 and own work experience 
during the pandemic. We additionally aimed to expand 
our understanding and explore some of the themes that 
were developed during analysis of the responses received 
during the first round more in depth.43 We added a 
section on the use of telemedicine, where we asked 
participants whether they used technology to counsel or 
provide care to women or their babies remotely, and if 
so, which services. We asked whether they received any 
guidelines on telemedicine provision. Finally, we also 
asked whether they used telemedicine in the same way 
compared with before the pandemic, more, or only 
started since the beginning of the pandemic.
In open text responses, we asked respondents to 
share the top three successes and challenges that they 
experienced using telemedicine. Further, respondents 
could share their general concerns about providing care 
during the pandemic in an open text box at the end of 
the questionnaire. The questionnaire was available in 11 
languages (English, French, Arabic, Italian, Portuguese, 
Spanish, Japanese, German, Dutch, Russian and Kiswa-
hili). The questionnaire is available publicly44 and the 
questions relevant to telemedicine are provided in online 
supplemental file 1.
Data processing and analysis
We included responses collected between 5 July 2020 
and 10 September 2020. We cleaned the 1331 responses 
received by removing duplicate submissions (n=14), 
refusals to participate (n=131), submissions with more 
than 85% of questions with missing answers (n=46) 
and submissions from respondents who skipped all the 
telemedicine questions (n=80). Quantitative and qual-
itative analyses were done simultaneously in a concur-
rent design. Quantitative analysis involved producing 
descriptive statistics (frequencies and percentages) using 
Stata/SE V.14. Descriptive statistics revealed the over- 
representation of healthcare providers from Kazakhstan 
in our sample. This was a result of a proactive dissemina-
tion of the survey by the Ministry of Health in Kazakh-
stan. A sensitivity analysis was conducted, showing that 
in Kazakhstan 67% of respondents used telemedicine vs 
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52% from other MICs. We did not apply any statistical 
corrections for the sampling because this mixed- methods 
analysis did not aim to make generalisable statements 
about telemedicine use by country income levels. The 
Kazakhstani responses were taken into consideration 
when summarising and interpreting the qualitative data.
All open- ended text responses were translated to 
English by AG (fluent in Spanish, Portuguese, English, 
Dutch and French) and by AS (Arabic), with additional 
assistance from the research team with translating and 
interpreting responses received in other languages. 
Responses to open- ended questions were analysed using 
Braun and Clarke’s six- phase framework for thematic 
analysis and inductive coding.43 This framework involves 
a reflexive process of moving forward (and sometimes 
backward) through data familiarisation, coding, theme 
development, revision, naming and writing up. The 
open- ended responses were read and reread in order 
to generate initial ideas. Data were then systematically 
coded by one researcher (AG), and the developed codes 
and themes were discussed on a weekly basis with the 
multidisciplinary coauthor team (including a midwife, 
nurse, medical doctor, anthropologist, maternal health 
epidemiologist and quantitative public health scientist). 
Inconsistent codes were rejected or adapted and over-
arching themes were developed. The last two phases 
involved refining the themes extracted from the data, 
adding quotes and double checking if the themes really 
reflected the respondents’ experiences and perceptions 
with feedback from the coauthor group. Throughout 
this process, we paid special attention to the context in 
which the participants’ experiences and thoughts were 
rooted (ie, country, position in the team, cadre). Finally, 
the continuum of maternal and newborn care was used as 
a framework for visualising the results.45
Patient and public involvement
No patient or public involvement took place in the design 
or conduct of this study. We involved health professionals, 
experts in health systems, infectious diseases, infection 
prevention and control, and health epidemiologists, and 
public health researchers from various global settings in 
the design of this study and the survey tool. We intend to 
disseminate the main results to several stakeholders and 
health professionals globally by social media and personal 
contacts, including to the participants of the study.
RESULTS
Table 1 displays the background characteristics of the 1060 
survey participants included in the analysis. Respond-
ents worked in 71 different countries, most commonly 
in Kazakhstan (n=507), the Democratic Republic of the 
Congo (n=43), Italy (n=43), Nigeria (n=37) and Japan 
(n=34). The most common cadres of health professionals 
in the sample were nurses (29%), midwives and nurse- 
midwives (25%), and obstetricians/gynaecologists (21%). 
The majority of respondents identified as women (78%). 




  High- income 277 (26)
  Middle- income 682 (64)
  Low- income 101 (10)
World region
  East Asia and Pacific 41 (4)
  Europe and Central Asia 675 (64)
  Latin America and Caribbean 66 (6)
  Middle East and North Africa 53 (5)
  North America 25 (2)
  South Asia 27 (2)
  Sub- Saharan Africa 173 (16)
Cadre
  Midwife/nurse- midwife 257 (25)
  Nurse 312 (29)
  Obstetrician/gynaecologist 223 (21)
  Neonatologist/paediatrician 73 (7)
  Medical doctor (no specialisation) 126 (12)
  Other 54 (5)
Position
  Head of facility 44 (4)
  Head of department or ward 103 (10)
  Head of team 87 (8)
  Team member 237 (22)
  Interim member 74 (7)
  Independent or self- practicing 110 (10)
  Other 360 (34)
Gender
  Female 826 (78)
  Male 213 (20)
  Prefer not to mention 7 (2)
Type of care provided (multiple responses 
allowed)
  Outpatient ANC 402 (38)
  Home- based childbirth care 76 (7)
  Outpatient PNC 321 (30)
  Outpatient breastfeeding support 255 (24)
  Inpatient ANC 284 (27)
  Inpatient childbirth care 362 (34)
  Inpatient PNC 325 (31)
  Surgical care 169 (16)
  Neonatal care (small and sick newborns) 157 (15)
  Home visits 152 (14)
  Community outreach 204 (19)
  Family planning provision or counselling 251 (24)
  Abortion care 139 (13)
  Post- abortion care 189 (18)
Continued
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Respondents were involved in providing outpatient ante-
natal care (ANC) (38%), outpatient PNC (30%), inpa-
tient childbirth care (34%) and inpatient PNC (31%). 
Three- quarters of respondents worked in public health 
facilities, almost half worked in urban settings (large and 
small cities), and 22% worked in villages or rural areas.
Among the entire sample, 58% of health professionals 
reported using some form of telemedicine (figure 1). 
This includes all those who used telemedicine more 
than before the pandemic, in the same way as before 
the pandemic, and those who started using telemedicine 
since the beginning of the pandemic. Three- quarters of 
respondents from LICs were not using telemedicine at 
all at the time of their response, compared with 41% of 
those working in HICs and 24% in MICs. The percentage 
of healthcare providers introducing telemedicine since 
the beginning of the pandemic was higher among those 
who worked in HICs and MICs (18% and 16%, respec-
tively) compared with LICs (1%).
Among the 612 respondents who provided healthcare 
using telemedicine, 65% used telemedicine to provide 
routine ANC, 59% used it to provide childbirth prepa-
ration sessions, half provided routine PNC and breast-
feeding counselling, 40% provided family planning 
counselling and 17% abortion care. Thirty- nine per cent 
of respondents using telemedicine reported that they did 
not receive guidelines on this mode of care provision.
The qualitative analysis focused on the main prac-
tices and challenges for implementing telemedicine 
during COVID-19 among maternal healthcare providers 
worldwide. We identified elements of care along the 
continuum of maternal and newborn healthcare which 
were commonly provided using telemedicine (figure 2). 
Those were further classified into different telemedicine 
practices within five broad categories: (1) education and 
counselling by telemedicine, (2) reducing or eliminating 
personal visits, (3) replacing in- person consultations 
by telemedicine, (4) setting up hotlines or information 
lines, and (5) providers connecting to one another by 
telehealth. The practices are explained more in detail in 
table 2, including the perceived benefits by providers and 
rationale for using them during the pandemic. Further-
more, we found eight general themes (not related to a 
specific component of care or practice) concerning the 
challenges encountered when providing telemedicine: 
lack of infrastructure, technological illiteracy, remote 
monitoring limitations, financial barriers, lack of non- 
verbal feedback, limited bonding, language barriers and 
distrust (figure 2).
Practices
The application of telemedicine along the five broad 
categories was slightly different according to the context, 
but they seemed to commonly exist in every world region. 
Healthcare providers using telemedicine were in general 
positive and enthusiastic about its potential for contin-
uing healthcare provision during the pandemic without 
a transmission risk. For example, a midwife from Norway 
commented that ‘telehealth is a brilliant way to have a 
look and give advice without being in touch.’
Providing online group birth preparedness classes 
during pregnancy was one of the most popular newly 
introduced telehealth practices mentioned by respon-
dents. They explained that telemedicine was a good 
alternative to face- to- face classes because education and 
counselling is an element of care which does not involve 
a physical examination. This care can be delivered easily 
by Zoom or other video- conferencing platform/mobile 
app, as explained by a midwife from Costa Rica: ‘It has 
been possible to continue childbirth preparation courses 
through teams or zoom. Furthermore most of the users 
have smartphones that allow them to access platforms to 
receive additional information afterwards.’ Respondents 
who mentioned using online group birth preparedness 
classes mostly worked in HICs or MICs, indicating that 
n (%)
  Other 147 (14)
Works in more than one health facility
  Yes 742 (70)
  No 300 (28)
Primary workplace
  Referral hospital 202 (19)
  District/regional hospital 196 (18)
  Health centre 91 (8)
  Polyclinic or clinic 280 (26)
  Birth centre 111 (10)
  Independent or self- practicing 67 (6)
  Other 94 (9)
Primary workplace sector
  Public (national) 532 (50)
  Public (university or teaching) 107 (10)
  Public (district level or below) 168 (16)
  Private for profit 28 (3)
  Private not- for- profit 25 (3)
  Independent or self- practicing 63 (6)
  Other 88 (8)
Type of area
  Large city (>1 million inhabitants) 355 (33)
  Small city (100 000–1 million inhabitants) 246 (23)
  Town (<100 000 inhabitants) 149 (14)
  Village/rural area 236 (22)
  Other 43 (4)
Workplace characteristics
  Facility provides caesarean section 535 (50)
  Facility accepts referrals from other facilities 672 (63)
*Differential number of missing values across variables.
†According to the World Bank classification.84
ANC, antenatal care; PNC, postnatal care.
Table 1 Continued
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this switch to remote technologies in the provision of 
health education, in particular group sessions, might 
have been less common and/or accessible in LICs. Note-
worthy, formally organised group classes are less common 
in general in some regions (eg, in many African coun-
tries health information is provided to women before/
after the start of the regular ANC consultations in health 
facilities, rather than specially organised birth prepared-
ness classes46 47), which might also explain why online 
group classes during the pandemic were not a commonly 
reported practice in those settings.
The second telehealth practice concerned the 
reduction or elimination of non- essential personal 
consultations. Providers did not seem to have a stan-
dard definition of what they considered as ‘essential’ 
versus ‘non- essential’ health consultations. Healthcare 
providers used email and/or WhatsApp to send prescrip-
tions and laboratory results to their patients if needed. 
This did not seem to be a completely new practice, but 
was more commonly performed since the beginning of 
the pandemic (as women and their families were discour-
aged from visiting health facilities unless absolutely neces-
sary) and easily accepted by patients and implemented by 
providers. Medical abortion was an example of a service 
mentioned within this theme. A doctor from Cameroon 
described how he assisted women with an abortion, by 
providing a medical prescription and a cervical- ripening 
agent remotely, to reduce the time spent with the patient 
in person: ‘One of the biggest successes of telemedi-
cine is preparing women with abortion remotely for 
surgical aspiration. I come to perform it when ready.’ He 
mentioned this telehealth practice was routine before 
the pandemic.
Third, providers commonly reported the application of 
telemedicine to replace face- to- face consultations. Prac-
tices that fall under this theme include conducting ante-
natal and postnatal consultations through video/phone 
calls (mostly WhatsApp) instead of in- person visits in the 
health facility or at the woman’s home. Contrary to the 
exchange of prescriptions and lab results, this seemed 
Figure 1 Percentage of respondents currently using technology to counsel or provide care to women or their babies remotely 
as compared with before the COVID-19 pandemic, by country income level (%, n=1060).
Figure 2 Key types of practices and challenges of providing care through telemedicine along the continuum of maternal and 
newborn healthcare (n=612) users of telemedicine during COVID-19 pandemic.
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an application of telemedicine newly introduced since 
the beginning of the COVID-19 pandemic. Respondents 
and patients in some countries were not able to access 
health facilities due to strict curfews, lockdowns, public 
transport bans and closures of health facilities, making 
face- to- face consultation almost completely impos-
sible. Telehealth was described as a solid alternative to 
compensate the lack of face- to- face consultations to some 
extent, although with limitations. A nurse- midwife from 
Uganda commented that ‘through phone calls to post-
natal mothers on breastfeeding, cord care, and thermal 
care, babies have survived although they were not able 
to access the health facilities for postnatal care.’ The 
practice of remote blood pressure or fetal heartbeat 
monitoring by women themselves (self- monitoring) was 
not reported by respondents, indicating that this was not 
a common practice in our sample. Importantly, respon-
dents reported cancelling some antenatal and postnatal 
consultations without replacement by any form of tele-
health, especially for pregnancies considered low risk. 
Currently, the WHO recommends eight ANC contacts 
for a low- risk pregnancy.48 Some providers reported 
reverting to a reduced number of ANC visits by using the 
pre-2016 WHO recommendation of four focused ANC 
visits.49 A midwife from Kenya explained that conducting 
fewer ANC consultations was done in order to reduce the 
Table 2 Commonly reported uses of telemedicine in maternal healthcare related to the COVID-19 pandemic and providers’ 
insights and perceived benefits
Practices Use of telemedicine Provider’s insights and perceived benefits
Education and counselling of women 
and their families
Providing birth preparedness classes by video  ►  Allows ongoing provision of important 
educational and supportive care.
 ►  Convenient because women and their 
partners can participate and continue with other 
tasks (caring for other children, for example) and 
do not need transport.
Postnatal (breastfeeding) counselling and 
support by video
 ►  During the COVID-19 pandemic women often 
had less access to support from family and 
friends, making postnatal support by healthcare 
providers (in particular, midwives) even more 
crucial.
Psychosocial counselling by phone/video  ►  Useful to address the generally increased 
levels of anxiety during the COVID-19 pandemic.
 ►  Effective to provide information and highly 
demanded by women and their families 
(especially regarding COVID-19 risks and 
potential negative consequences for mother and 
baby if infected).
Reducing or eliminating personal 
visits
Prescriptions (contraception, medication, 
medical abortion pill) by WhatsApp/email
Lab results exchange by WhatsApp/email
 ►  Visits to the facility can be avoided by giving 
prescriptions and/or medications for longer 
periods than usual.
 ►  Face- to- face consultation time can be 
reduced or eliminated when people receive 
digital information/prescriptions/lab results.
Replacing in- person consultations 
with telemedicine
Antenatal and postnatal care consultations by 
phone/video
 ►  More often used if pregnancies were low risk, 
while high risk often continued with in- person 
visits.
 ►  Often a personal decision by the health 
provider whether to replace in- person visits by 
telehealth or not, because of the lack of official 
guidelines.
 ►  Easy to schedule a convenient time for 
woman and health provider.
Setting up hotlines or information 
lines to provide guidance on care 
seeking
Women with (potential) signs of labour are 
recommended to call the maternity ward 
before going to the hospital
Institutional hotline for all questions regarding 
maternity care during COVID-19
 ►  Hospital visits can be avoided by giving 
correct information and telephone counselling 
for women with questions or early signs of the 
start of labour.
Providers connecting to one another 
to provide better care coverage/
quality
  Increased professional communication, 
collaboration and training:
 ►  Exchange through WhatsApp/email/
phone
 ►  Online seminars/training sessions
 ►  Online simulations
 ►  Highly used for interdisciplinary care for 
pregnant and/or postpartum women suspected 
or confirmed with COVID-19.
 ►  Useful for discussing concerns regarding 
high- risk patients.
 ►  Potential to avoid referrals by receiving input 
from experts.
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risk of infection during an ANC visit: ‘Overall, we have 
less consultations because we give women less appoint-
ments so that we reduce the risk of being contaminated 
during consultation.’
Respondents reported that care during labour and 
delivery was provided in person during the COVID-19 
pandemic. Women continued to be advised to give birth in 
health facilities. Nevertheless, many healthcare providers 
reported a decrease in the number of facility- based births 
during the pandemic. The only new applications of tele-
health for intrapartum care during the pandemic were 
that women in labour were requested to make a phone 
call before travelling to the hospital. In addition, in 
circumstances of shortened hospital stays after childbirth 
(in some cases just a couple of hours after birth up to a 
maximum of 48 hours for a normal delivery), the first 
days of postpartum care were almost entirely delivered by 
outpatient care, which was frequently done by telehealth. 
Some respondents mentioned that only the 6- week post-
partum visit was retained as an in- person visit, because 
it coincides with the newborn’s vaccination schedule. 
Respondents also reported that women were more in 
need of guidance and support during the postpartum 
period (for example with breast feeding), in part also 
due to reduced informal support by friends and family.
The fourth telehealth practice was established as 
healthcare providers tried to respond to what they 
described as higher levels of anxiety, psychosocial prob-
lems, questions and insecurity among pregnant and 
postpartum women, all instigated by the pandemic. 
Women wanted more information about the effects of a 
COVID-19 infection on pregnancy and newborn, as well 
as information about COVID-19- related restrictions and 
procedures in the hospital. Healthcare workers reported 
using online consultations, phone calls and text messages 
to provide this information and support. Some health 
facilities also temporarily installed telephone hotlines to 
answer patients’ questions. Telehealth seemed to grant 
healthcare providers, midwives in particular, a feeling 
of connectedness with and care for their patients under 
the difficult circumstances of COVID-19. A midwife from 
Bangladesh described how telehealth combated loneli-
ness and even saved lives: ‘By providing telehealth first of 
all women are not completely alone. Besides that, it also 
has saved lives because I advised women by the phone 
to come on time for the delivery and provided remote 
abortion care.’
Fifth, beyond the application of telemedicine as a means 
of contact between patients and providers, we found that 
many providers reported a positive effect of the pandemic on 
collaboration between health facilities and among healthcare 
providers. They reported an increase in the use of telecom-
munication for exchange of information and expertise both 
among colleagues and at institutional levels. A midwife from 
Germany explained how team work improved as a conse-
quence: ‘One of the successes during COVID in my organi-
zation were the more frequent team meetings, partially done 
online, which enabled uniform action against the spread of 
the virus.’ Healthcare providers also mentioned improved 
interdisciplinary collaboration by sharing guidelines (mostly 
clinical COVID-19 protocols) and updates by WhatsApp/
email/phone calls. The restrictions regarding physical 
training courses also increased providers’ participation in 
online training modules and simulations.
Challenges
Among the healthcare providers providing telemedicine 
(n=612), almost half (n=282, 46%) reported challenges 
with this mode of service provision in open text responses. 
The decision to offer telehealth often seemed a personal 
decision made by health providers, based on a risk–benefit 
assessment. Eight broad categories of challenges were iden-
tified: lack of infrastructure, technological illiteracy, remote 
monitoring limitations, financial barriers, lack of non- verbal 
feedback, limited bonding, language barriers and distrust. 
Among respondents using telemedicine in the same way 
as before the pandemic only the first two challenges were 
reported. Among respondents introducing telemedicine 
during the pandemic or using it more than before, all eight 
challenges were reported.
Lack of infrastructure
Most healthcare providers seemed to use their own smart-
phone for providing telehealth services and one of the 
biggest challenges reported was poor internet connection 
and/or regular interruptions in connectivity. This was a 
global problem reported by providers from both LMICs and 
HICs. As noted by a midwife in the USA: ‘Trying to connect 
with women from rural areas with poor wi- fi service was a 
challenge.’ In LICs, electricity cuts were also mentioned by 
several respondents, affecting their ability to provide tele-
health, as described by a midwife in Nepal: ‘The electricity 
cuts are bothering the most. Besides, internet fall outs.’
Technological illiteracy
Lack of skills to manage the software and devices for 
conducting telehealth seemed a major obstacle for both 
women and health providers. While people might have 
access to the necessary equipment (such as a smartphone), 
they were reluctant to use it for telehealth because they do 
not know how to handle the technology correctly. Installing 
and using the necessary app on a mobile phone or program 
on the computer seemed the most difficult step for many 
people, although it was difficult to understand at which point 
problems emerged from providers’ reports. A midwife from 
France noted that: ‘Women do not always understand how 
to use the technology properly.’ Also at the provider’s side 
a midwife from Argentina mentioned a lack of technolog-
ical skills: ‘Many providers do not use telemedicine because 
learning the skills to do it are a personal responsibility instead 
of an institutional responsibility.’
Remote monitoring limitations
Healthcare providers reported that their inability to perform 
physical examinations (such as fetal heartbeat monitoring, 
blood pressure measurement or assessing fundal height) 
was one of the most important shortcomings of antenatal, 
Galle A, et al. BMJ Global Health 2021;6:e004575. doi:10.1136/bmjgh-2020-004575 9
BMJ Global Health
postnatal and neonatal consultations through video/phone 
calls. A neonatologist in Japan who was providing care for 
women and their newborns after discharge described the 
most important challenges as follows: ‘When I do an online 
consultation I cannot do any direct examination, I cannot 
observe any reaction to an examination and I cannot do any 
medical scan.’
Financial barriers
While many providers were very enthusiastic about the use 
of telemedicine, they also noted that it is not affordable for 
many of their patients because they lack the financial means 
to purchase the necessary technical devices or airtime (also 
called talk- time or data allowance). WhatsApp (installed on 
a smartphone) was mentioned as communication medium 
most often and also preferred by healthcare providers, but 
it became clear that not everyone had a smartphone at their 
disposal. This was a recurring theme in both LMICs and 
HICs. A medical doctor in India wrote that ‘the use of the 
phone, SMS and WhatsApp is a success for telemedicine but 
only 30% of the people have a smartphone.’
Respondents themselves faced financial burdens from the 
use of telemedicine on two levels: not being able to afford the 
equipment and lack of reimbursement. Several mentioned 
the absence of reimbursement for costs they incurred while 
providing telemedicine (including the telehealth consulta-
tion itself and its associated internet/phone/data costs). 
Respondents from LICs particularly reported that there 
was no standard way of getting reimbursed for providing 
telehealth consultations. Many patients did not have insur-
ance or insurance companies did not cover the telemedi-
cine consultations. Providers did not know how to invoice 
the telemedicine consultations as patients were not coming 
personally anymore. In addition, particularly midwives often 
mentioned the burden of having to pay the internet/phone 
costs from their own pocket; this was perceived as a serious 
additional barrier. These financial issues were affecting 
healthcare providers’ willingness and ability to provide 
care, as noted by a midwife in Kenya in regard to the cost 
of mobile data: ‘Sometimes I cannot do a follow up of the 
patients because of lack of airtime.’
Lack of non-verbal feedback
Many healthcare providers reported they could not be 
assured that the health information was well understood 
by women because they could not read their facial and/or 
body expressions. Midwives reported this problem more 
frequently than obstetricians. A midwife in Nigeria elabo-
rated: ‘I don't like offering remote care. I feel that if you are 
not seeing the non- verbal cues and facial expression of your 
patient, you will not truly know if they are ok.’
Limited relationship and bonding
Closely related to the lack of non- verbal feedback, also the 
relationship and bond between the midwife and a woman 
was affected by telemedicine. This was described by a 
midwife in the USA as follows: ‘Technology is a good tool, 
but does not replace face- to- face conversations, palpating 
a mom’s abdomen, and listening to the baby’s heart rate 
in order to form warm, trusting bonds between a patient 
and the midwife.’ This theme was typical among midwives 
who felt that the personal interaction was part of ‘being a 
midwife’: ‘My main concern is that we are not at the bedside 
as midwives traditionally are’, noted a midwife in the USA.
Language barriers
Language barriers were perceived to be more problematic 
during telemedicine compared with in- person consultations. 
Healthcare providers found it easier to overcome language 
barriers during in- person visits by using body language, 
which was not feasible virtually. Also, the use of interpreters 
was sometimes not possible or more problematic for online 
consultations compared with face- to- face visits. A nurse- 
midwife from the USA described how both language barriers 
and financial barriers hampered access to telehealth: ‘Using 
medical interpreters over the video is a real challenge. 
Furthermore, our most disadvantaged patients also have 
limited access to telephone or video.’
Distrust
Healthcare providers perceived that some patients had little 
trust in the care provided through telemedicine and were 
reluctant to accept it. One specific problem perceived by 
health providers was that undocumented migrants refused 
telehealth consultations because they were afraid to be 
recorded during such interactions and feared a possible 
prosecution. A midwife in the USA explained: ‘Many of 
my patients are not documented or are in the U.S. tempo-
rarily, and are thus reluctant to participate in video and tele-
phone visits due to well- grounded fears of information being 
recorded or listened to by government agencies.’
DISCUSSION
This study used a rapid global online survey to understand 
the care process adaptations used by more than a thou-
sand maternal and newborn health providers from over 70 
countries during the COVID-19 pandemic. We found that 
telemedicine was frequently used for various services along 
the continuum of maternal and newborn healthcare and 
differed somewhat across contexts. The choice of providing 
telemedicine was often a personal decision of each health 
professional, rather than a health facility policy, or a country 
guideline. This means that some healthcare providers 
reported that personal financial costs were a serious barrier 
to provision. Telemedicine was already practised to a certain 
extent before the pandemic by two- fifths of the respondents, 
but more widely implemented during the pandemic by one 
in five. Some healthcare providers also introduced telemedi-
cine for the first time during the pandemic. Health providers 
implementing telemedicine for the first time or using it more 
often during the pandemic faced more challenges than those 
using it to the same extent as before. Globally, maternal and 
newborn health providers in LICs seem to face more severe 
barriers to implement telehealth practices compared with 
those in middle- income and high- income settings.
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In this paper, we show that maternal and newborn health 
professionals adapted the provision of care using telemed-
icine during the COVID-19 pandemic in many different 
ways, even within similar settings. The lack of evidence- 
based consolidated national or global guidelines together 
with a legal framework on the usage of telehealth might 
explain these findings.9 16 Among healthcare providers who 
were using telemedicine, two- fifths reported that they did 
not receive any guideline on the provision of care through 
telemedicine. Currently, guidelines on telemedicine mostly 
originate from national medical specialty societies outside 
maternal healthcare provision and are not tailored to the 
context of a pandemic, limiting their transferability to other 
health domains and contexts.9 Furthermore, health systems 
and governments did not seem to be prepared for the rapid 
evolution of the pandemic, and maintaining the provision of 
maternal and newborn healthcare might not have been their 
first priority. Only after the first pandemic peak in March/
April 2020 did the first reports of a potential disruptive effect 
of the pandemic on maternal and newborn care provision 
start to emerge,7 50–53 allowing more coordinated action from 
stakeholders and governments.
Our study showed that several factors played a role in the 
decision of healthcare providers on whether to implement 
telehealth during COVID-19, for which care and to which 
patients. These factors included a risk–benefit assessment, 
personal preference of the provider and patient, financial 
consequences and health status of the women (low- risk vs 
high- risk pregnancies). Some healthcare providers declared 
that they only saw women with a high- risk pregnancy and 
shifted entirely to telemedicine for low- risk women. Other 
providers and facilities shifted to the previous recom-
mendation of four focused ANC visits for low- risk preg-
nancies,48 49 replacing some of the remaining visits with 
telemedicine consultations or a hotline in case of emergen-
cies and questions. A recent publication from India described 
a similar approach here advising face- to- face ANC provision 
for high- risk pregnant women and a reduced number of 
visits for low- risk women, although they also claimed that 
more robust data are needed to evaluate the effectiveness of 
their approach.54 Obstetric care is characterised by unpre-
dictability; women may develop complications throughout 
their pregnancy, even when they were classified as low risk.55 
As a consequence, a low- risk profile might change to high 
risk rapidly without warning. Such changes in risk status may 
go unnoticed, given that healthcare providers reported that 
providing care via telehealth risks losing certain essential 
information (related to non- verbal feedback and physical 
examinations), which they believed might affect the quality 
of care. Previous evidence showed that receiving fewer ANC 
consultations than the recommended has a negative effect 
on maternal and newborn health outcomes.56–58 Unfortu-
nately, evidence- based guidelines about the ideal number 
of telehealth visits versus face- to- face visits during pregnancy 
and post partum are lacking, together with guidelines on the 
integration of home- based equipment (eg, blood pressure 
monitor, glucometer, urine analysis test strips) which could 
provide important information to increase care quality 
and detection of possible complications. In- depth research 
is needed to assist healthcare providers with guidance on 
how to implement telehealth along the continuum of 
maternal and newborn healthcare, and ensure the provision 
of high- quality maternal health services through blended 
approaches.
Our study showed that many providers experienced 
serious challenges in organising and conducting telecon-
sultations. The most important challenges when providing 
telehealth included lack of infrastructure, technological illit-
eracy, financial barriers, remote monitoring limitations, lack 
of non- verbal feedback, limited bonding, language problems 
and distrust from patients. Lack of infrastructure varied from 
internet connection problems to a lack of smartphones and/
or other devices at one or both sides of the clinical encounter 
(providers and patients). While the lack of internet and 
equipment was most often reported in LICs,59 it appeared to 
be a global problem according to our data and also common 
among health providers being familiar with telemedicine 
(ie, those using it already before the pandemic). Our study 
showed that a large proportion of healthcare providers and 
patients do not have easy and affordable access to telemed-
icine equipment and mobile/data networks. Furthermore, 
recent research has revealed a gender gap in mobile internet 
use in LMICs with women being 20% less likely to use mobile 
internet than men.60 Given that maternal health is primarily 
directed to women and that majority of maternal healthcare 
workers are women, this gender gap will negatively affect 
the use of telehealth for maternal healthcare. If telehealth 
is intended to fill the gaps of healthcare provision during 
periods of disruptions to healthcare supply and utilisation, 
or even an essential part of the general healthcare system, 
this access issue will need to be addressed, possibly through 
government subsidies or grants for the most disadvantaged 
groups.61
Technological illiteracy was another problem commonly 
reported in our study by respondents from all types of coun-
tries. Offering education programmes, investing in user- 
friendly software and social outreach programmes might 
all be strategies to reduce technological illiteracy and the 
hidden digital inequality and health disparities62 that might 
emerge with wider telemedicine use. Financial issues in 
using telehealth seemed most problematic in LICs for both 
providers and patients, according to our study. A big share 
of women cannot afford to buy airtime for consultations and 
do not have access to (smart) phones. Healthcare providers 
also reported struggling to afford equipment and airtime. In 
addition, especially healthcare providers from LMICs found 
it difficult to get paid for telehealth consultations due to a 
lockdown and/or lack of reimbursement system (by a health 
institution or social security system). In contrast, health 
providers in HICs often had access to phones and internet 
offered by their institutions. Furthermore, health insurance 
companies are increasingly covering the main part of the 
telehealth consultations in line with regular care in several 
HICs, which makes the financial compensation for telehealth 
less problematic for them.63–65 It is noteworthy that rapidly 
evolving technological solutions are coming up in both LICs 
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and HICs (for example, by allowing money transfer by SMS 
or WhatsApp66 67), which might overcome certain barriers 
for providing telehealth in the future.
In our study, telemedicine was mostly performed by 
conducting video consultations without reports of patients 
self- monitoring of vital signs, fetal heartbeat or glucose levels. 
Providers reported this as a challenge (described as ‘remote 
monitoring limitations’) and serious risk for guaranteeing 
high- quality care. Indeed, very little is known about the bene-
fits and risks of introducing this simplified method and scope 
of telehealth for providing maternal and newborn health-
care worldwide. Currently, evaluation studies or randomised 
controlled trials are hardly available within the literature 
regarding this new way of healthcare provision, and more 
research is definitely needed to discover its impact on women 
and newborns’ health outcomes.
Distrust, language problems, lack of non- verbal feedback 
and bonding were reported as barriers to telemedicine in our 
study. A study in Bangladesh reporting very similar barriers 
with telemedicine explained this by emphasising that a 
provider’s physical presence can easily express empathy and 
compassion non‐verbally, while this is much more difficult 
during a telehealth consultation.68 A similar concern was 
reported by midwives in our study who revealed they could 
not build a warm and trusting bond with the women by tele-
health consultations.
Healthcare providers who introduced telemedicine during 
the pandemic or used it more often faced more serious 
barriers compared with those using telemedicine in the same 
way as before. Most of the reported challenges in this study 
seem related to the rapid scale- up of telemedicine, whereby 
face- to- face consultations were almost completely impossible 
due to several COVID-19- related restrictions. We assume 
health providers using telemedicine to the same extent as 
before the pandemic faced fewer challenges, allowing a 
more balanced and natural way of telemedicine provision. 
The latest evidence from other health domains shows that 
digital modes of communication work best for patients and 
clinicians who have already previously established relation-
ships, with a flexible use of telecommunication according 
to patient condition and background.18 We believe that also 
in maternal healthcare a more balanced and natural combi-
nation of face- to- face and telemedicine contacts between 
women and health providers, under more flexible circum-
stances, might improve the experience of women and health-
care providers with telemedicine consultations in the future.
Contrary to the challenges of telemedicine, the benefits of 
telehealth applications in maternal healthcare are well docu-
mented. Many studies show that shifting to telemedicine for 
certain aspects of care is equally beneficial as face- to- face 
care when it comes to health outcomes and patient satisfac-
tion.69–72 However, it is important to note that these studies 
mainly derive from the USA and are conducted in a highly 
controlled setting with adequate equipment for remote 
monitoring of blood pressure and blood glucose levels.69 70 72 
One study in Japan also reported successful telemedicine 
provision during COVID-19 by documenting their remote 
ANC consultation procedure that included the mailing 
of a cardiotocograph and a sphygmomanometer to each 
pregnant woman’s home for remote monitoring.73 Unfortu-
nately, these telehealth interventions do not correspond with 
the global practice of telehealth during the pandemic, where 
it has been applied in very different ways and under subop-
timal circumstances. Furthermore, telehealth is an already 
dynamic and rapidly evolving field, resulting in additional 
challenges for in- depth monitoring and evaluation of new 
applications.16
Our study suggests that vulnerable groups are at risk of 
being excluded from telemedicine, perhaps even higher 
than from routine in- person maternal healthcare. Given 
that groups such as single women, adolescents, migrants and 
women of low socioeconomic status already face challenges 
in reaching face- to- face maternal healthcare services,74–76 it is 
crucial that shifting to telehealth does not exacerbate these 
inequalities. It is important to note that even with concrete 
guidelines regarding the implementation of telehealth, a 
one- size- fits- all model will not be appropriate. Each country 
must continually assess which groups of society are vulner-
able to exclusion and fairly support those at the highest risk.77
Our study showed that in general, providers appreciated 
the application of telemedicine and that it was often the only 
way to ‘connect’ with women, families and their newborns. 
Midwives reported higher levels of loneliness and depres-
sion among both pregnant and postpartum women, which 
is in line with the first studies in the field of maternal mental 
health during the COVID-19 era and previous epidemic 
outbreaks.78–80 On one hand the virtual meetings, coun-
selling and support by midwives can help women, but on 
the other they are only partially doing ‘the job’ because of 
the lack of physical contact and bonding. More research is 
needed on how the mental health needs in the perinatal 
period can be addressed by telehealth during a pandemic or 
similarly disruptive situations.81 82
Lastly, the COVID-19 pandemic seemed to boost the 
communication and interdisciplinary management of care 
between healthcare providers by mobile technologies. Our 
study showed that the increased ability to reach colleagues 
and specialists for advice was valuable to healthcare providers 
during the pandemic, besides receiving up- to- date guidelines 
by virtual communication. Furthermore, they explained 
it could avoid unnecessary referrals between hospitals by 
soliciting advice from experts by phone. A Cochrane review 
also showed that mobile health communication between 
providers probably decreases the time to deliver health-
care, as well as the number of face- to- face appointments,83 
both essential aspects of the global strategy to reduce the 
spread of the COVID-19 virus. It is critical that this improved 
collaboration and communication will be continued after 
the pandemic, as the benefits and lessons learnt will be 
important to tackling long- standing issues such as communi-
cation during the referral process.
Limitations
Limitations of our study are the sample bias and lack of repre-
sentativeness, due to the convenience sampling approach. 
We received few responses from professionals working in 
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lower level facilities, particularly in LICs, which might itself 
be related to limited access to the internet in these settings. 
Our sample might over- represent higher qualified cadres 
of health professionals in settings with limited use of tech-
nology among lower cadres of staff, and under- represent 
overwhelmed providers, and those with limited access to 
internet connection. This is particularly relevant for the topic 
of this analysis, as we might overestimate the use of telehealth 
because of the sample that we reached. Another limitation 
of this study is the cross- sectional design, whereby we only 
captured the experiences of providers at one given moment. 
While we could grasp from the responses which telemedi-
cine practices were applied more often or introduced during 
the pandemic, it was not always clear to determine to what 
extent these practices were used before the pandemic. 
Follow- up research, using a longitudinal design, could deter-
mine to what extent certain telehealth applications continue 
and evolve over time and after the pandemic, assessing their 
perceived benefits and challenges for maternal healthcare 
provision in the long term. Lastly, the findings related to the 
positive effect of the crisis on professional telecommunica-
tion and collaboration were presented briefly and grouped 
together as one telehealth practice because they were not 
the focus of our study. Nevertheless, they are equally impor-
tant, especially for improving maternal health outcomes 
and health providers’ work satisfaction. We believe further 
research is needed with regard to this particular aspect of tele-
health, to support long- term improvements in collaboration 
and multidisciplinary teamwork among health providers.
CONCLUSION
Maternal and newborn health providers considered tele-
health to be an important alternative to providing certain 
health services during the first months of the COVID-19 
pandemic. It gave them the possibility to connect with 
patients and interact with other health professionals without 
being exposed to the risks of in- person contact, or when 
facing restrictions to movement. Furthermore, telehealth 
seems to be less time- consuming (sometimes with equal 
financial compensation) and can easily be combined with 
other duties at home or in health facilities. However, more 
research is needed to understand the consequences of an 
extensive telehealth consultation schedule in maternal and 
newborn health during the COVID-19 pandemic. Some 
authors already pointed to the risk of loneliness and depres-
sion for women giving birth during the pandemic, where the 
lack of interpersonal contact during the postpartum period 
and increased stress levels seemed serious triggers. We believe 
the negative consequences might go beyond that, taking into 
account the reduced number of in- person ANC visits and 
digital inequality that goes hand in hand with providing tele-
health. Illiterate, migrant, poor and ethnic minority women 
appear to be particularly left behind in accessing maternal 
health by telehealth. More research regarding the effective-
ness and efficacy of telehealth for maternal healthcare in 
different contexts is highly needed before implementing 
such adaptations in the long term and on a large scale, 
particularly to avoid an increase in the existing wide inequal-
ities in access to maternal healthcare worldwide.
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